Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
205 studies found for:    abiraterone
Show Display Options
Rank Status Study
1 Recruiting Optimizing Abiraterone Therapy
Condition: Metastatic Castration Resistant Prostate Cancer
Intervention: Other: Abiraterone Acetate
2 Active, not recruiting Abiraterone Acetate for Castrate Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Abiraterone;   Drug: Prednisone
3 Terminated
Has Results
Abiraterone Acetate Trial in African American Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Drug: Abiraterone Acetate
4 Active, not recruiting Abiraterone Post Ketoconazole for Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Abiraterone acetate
5 Terminated Abiraterone-Rechallenge Study for CRPC Patients
Condition: Prostate Cancer
Intervention: Drug: abiraterone acetate
6 Completed A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency
Condition: 21-hydroxylase Deficiency
Intervention: Drug: Abiraterone acetate
7 Recruiting Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Abiraterone Acetate
8 Recruiting PROSABI: Prospective Multi-centre Study of Prognostic Factors in CRPC Treated With Abiraterone
Condition: Prostate Cancer
Intervention: Drug: Abiraterone
9 Completed A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male Participants
Condition: Healthy
Interventions: Drug: Abiraterone acetate;   Drug: Rifampicin
10 Active, not recruiting Abiraterone Acetate in Molecular Apocrine Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Abiraterone Acetate
11 Active, not recruiting Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma
Conditions: Cushing Syndrome;   Adrenocortical Carcinoma
Intervention: Drug: Abiraterone Acetate
12 Active, not recruiting A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer
Condition: Castration Resistant Prostate Cancer
Interventions: Drug: Abiraterone Acetate;   Drug: Prednisone
13 Recruiting Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers
Condition: Salivary Glands Tumors
Intervention: Drug: Abiraterone acetate
14 Recruiting A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Abiraterone Acetate
15 Active, not recruiting Sequencing Abiraterone and Enzalutamide in mCRPC
Condition: Metastatic Castration-Resistant Prostate Cancer
Interventions: Drug: Abiraterone acetate;   Drug: Enzalutamide
16 Active, not recruiting Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Abiraterone acetate;   Drug: Prednisone
17 Recruiting Safety and Efficacy of Radiotherapy Combined With a 6-month LH-RH Agonist and Abiraterone Hormone Therapy Treatment in Biochemically-relapsing Prostate Cancer Following Surgery
Condition: Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
Intervention: Drug: Abiraterone
18 Completed
Has Results
A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Neoplasms;   Prostate Cancer
Interventions: Drug: Abiraterone;   Drug: Prednisone
19 Completed A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostate Neoplasms
Interventions: Drug: Abiraterone acetate;   Drug: Prednisone
20 Completed A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function
Condition: Prostate Cancer
Intervention: Drug: Abiraterone acetate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.